Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4170483
Max Phase: Preclinical
Molecular Formula: C20H14Cl2N2O
Molecular Weight: 369.25
Molecule Type: Small molecule
Associated Items:
ID: ALA4170483
Max Phase: Preclinical
Molecular Formula: C20H14Cl2N2O
Molecular Weight: 369.25
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1nc(-c2ccc(C)cc2)cc(-c2ccc(Cl)cc2Cl)c1C#N
Standard InChI: InChI=1S/C20H14Cl2N2O/c1-12-3-5-13(6-4-12)19-10-16(17(11-23)20(24-19)25-2)15-8-7-14(21)9-18(15)22/h3-10H,1-2H3
Standard InChI Key: SLRMNIHCMRJBAJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 369.25 | Molecular Weight (Monoisotopic): 368.0483 | AlogP: 5.91 | #Rotatable Bonds: 3 |
Polar Surface Area: 45.91 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 0.03 | CX LogP: 6.45 | CX LogD: 6.45 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.58 | Np Likeness Score: -1.50 |
1. Soliman EA, Panda SS, Aziz MN, Shalaby EM, Mishriky N, Asaad FM, Girgis AS.. (2017) Synthesis, molecular modeling studies and bronchodilation properties of nicotinonitrile containing-compounds., 138 [PMID:28753516] [10.1016/j.ejmech.2017.07.025] |
Source(1):